The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate

Steven Russell; Pontus M.A. Siren; Matus J. Siren; Michael Tisdale

doi:10.1038/sj.bjc.6605562

The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate

Steven Russell
, Pontus M.A. Siren
, Matus J. Siren
, Michael Tisdale

JGK Memorial Research Library and Laboratory
Adolf Fredriks Kyrkogata, Stockholm

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

77 Downloads (Pure)

Abstract

Background: D-myo-inositol-1,2,6-triphosphate (a-trinositol, AT) is a polyanionic molecule capable of chelating divalent metal ions with anti-tumour and anti-cachectic activity in a murine model.
Methods: To investigate the role of zinc in this process, mice bearing cachexia-inducing MAC16 tumour were treated with AT, with or without concomitant administration of ZnSO4.
Results: At a dose of 40mgkg-1, AT effectively attenuated both weight loss and growth of the MAC16 tumour, and both effects were attenuated by co-administration of Zn2+. The concentration of zinc in gastrocnemius muscle increased with increasing weight loss, whereas administration of AT decreased the levels of zinc in plasma, skeletal muscle and tumour, which were restored back to control values after administration of ZnSO4.
Conclusion: These results suggest that zinc is important in both tumour growth and cachexia in this animal model.

Original language	English
Pages (from-to)	833–836
Number of pages	3
Journal	British Journal of Cancer
Volume	102
Issue number	5
DOIs	https://doi.org/10.1038/sj.bjc.6605562
Publication status	Published - 9 Feb 2010

Bibliographical note

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
To obtain permission to re-use content from this article visit RightsLink.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

cachexia
a-trinositol
zinc
tumour growth

Access to Document

10.1038/sj.bjc.6605562Licence: CC BY-NC-SA 3.0

The role of zinc in the anti-tumour and anti-cachectic activity
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ To obtain permission to re-use content from this article visit RightsLink.
Final published version, 250 KBLicence: CC BY-NC-SA 3.0

Cite this

@article{27538f8af69d40eeb1655b7245b05398,

title = "The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate",

abstract = "Background: D-myo-inositol-1,2,6-triphosphate (a-trinositol, AT) is a polyanionic molecule capable of chelating divalent metal ions with anti-tumour and anti-cachectic activity in a murine model. Methods: To investigate the role of zinc in this process, mice bearing cachexia-inducing MAC16 tumour were treated with AT, with or without concomitant administration of ZnSO4. Results: At a dose of 40mgkg-1, AT effectively attenuated both weight loss and growth of the MAC16 tumour, and both effects were attenuated by co-administration of Zn2+. The concentration of zinc in gastrocnemius muscle increased with increasing weight loss, whereas administration of AT decreased the levels of zinc in plasma, skeletal muscle and tumour, which were restored back to control values after administration of ZnSO4. Conclusion: These results suggest that zinc is important in both tumour growth and cachexia in this animal model.",

keywords = "cachexia, a-trinositol, zinc, tumour growth",

author = "Steven Russell and Siren, \{Pontus M.A.\} and Siren, \{Matus J.\} and Michael Tisdale",

note = "From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ To obtain permission to re-use content from this article visit RightsLink.",

year = "2010",

month = feb,

day = "9",

doi = "10.1038/sj.bjc.6605562",

language = "English",

volume = "102",

pages = "833–836",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer",

number = "5",

}

TY - JOUR

T1 - The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate

AU - Russell, Steven

AU - Siren, Pontus M.A.

AU - Siren, Matus J.

AU - Tisdale, Michael

N1 - From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ To obtain permission to re-use content from this article visit RightsLink.

PY - 2010/2/9

Y1 - 2010/2/9

N2 - Background: D-myo-inositol-1,2,6-triphosphate (a-trinositol, AT) is a polyanionic molecule capable of chelating divalent metal ions with anti-tumour and anti-cachectic activity in a murine model. Methods: To investigate the role of zinc in this process, mice bearing cachexia-inducing MAC16 tumour were treated with AT, with or without concomitant administration of ZnSO4. Results: At a dose of 40mgkg-1, AT effectively attenuated both weight loss and growth of the MAC16 tumour, and both effects were attenuated by co-administration of Zn2+. The concentration of zinc in gastrocnemius muscle increased with increasing weight loss, whereas administration of AT decreased the levels of zinc in plasma, skeletal muscle and tumour, which were restored back to control values after administration of ZnSO4. Conclusion: These results suggest that zinc is important in both tumour growth and cachexia in this animal model.

AB - Background: D-myo-inositol-1,2,6-triphosphate (a-trinositol, AT) is a polyanionic molecule capable of chelating divalent metal ions with anti-tumour and anti-cachectic activity in a murine model. Methods: To investigate the role of zinc in this process, mice bearing cachexia-inducing MAC16 tumour were treated with AT, with or without concomitant administration of ZnSO4. Results: At a dose of 40mgkg-1, AT effectively attenuated both weight loss and growth of the MAC16 tumour, and both effects were attenuated by co-administration of Zn2+. The concentration of zinc in gastrocnemius muscle increased with increasing weight loss, whereas administration of AT decreased the levels of zinc in plasma, skeletal muscle and tumour, which were restored back to control values after administration of ZnSO4. Conclusion: These results suggest that zinc is important in both tumour growth and cachexia in this animal model.

KW - cachexia

KW - a-trinositol

KW - zinc

KW - tumour growth

UR - https://www.scopus.com/pages/publications/77649275282

UR - http://www.nature.com/bjc/journal/v102/n5/full/6605562a.html

U2 - 10.1038/sj.bjc.6605562

DO - 10.1038/sj.bjc.6605562

M3 - Article

SN - 0007-0920

VL - 102

SP - 833

EP - 836

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 5

ER -

The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate

Abstract

Bibliographical note

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this